Regulators should put a stop to tactics that delay the introduction of generic drugs.
Read this article from The Economist here.
Abonneren op:
Reacties posten (Atom)
skip to main |
skip to sidebar
Volgers
Blogarchief
- ► 2010 (1071)
-
▼
2009
(668)
-
▼
augustus
(111)
-
▼
aug 13
(18)
- Low Life Expectancy in the United States: Is the H...
- Technologie en werk!
- Health 2.0 could shock the system
- De financiële crisis!
- Islam and heresy - Where freedom is still at stake
- Generic drugs and competition - Something rotten
- Economists, economics, and the crisis
- Simple explanations for global financial instabili...
- It's Not a Recession, and It's Not Over
- The World Recession is Ending: What Next? Becker
- Obesity and Healthcare Costs
- Health Reform: Simple or Not?
- Health care reform: a free market perspective
- Cap-and-Trade's Unlikely Critics: Its Creators
- Something rotten
- Wonky Talk about Carbon Taxes
- Will technology make workers obsolete?
- Economists, economics, and the crisis
-
▼
aug 13
(18)
-
▼
augustus
(111)
Geen opmerkingen:
Een reactie posten